Intestinal microbiota and neuroinflammation in Parkinson's disease: At the helm of the gut-brain axis.
Int Rev Neurobiol
; 167: 81-99, 2022.
Article
en En
| MEDLINE
| ID: mdl-36427960
ABSTRACT
Emerging data suggest that disrupted intestinal microbiota, or dysbiosis, may be responsible for multiple features of Parkinson's disease (PD), from initiation, to progression, to therapeutic response. We have progressed greatly in our understanding of microbial signatures associated with PD, and have gained important insights into how dysbiosis and intestinal permeability promote neurodegeneration through neuroinflammation and Lewy body formation. These insights underscore the potential of microbiota-directed therapies, which include dietary, pharmacologic, and lifestyle interventions.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedad de Parkinson
/
Microbioma Gastrointestinal
Límite:
Humans
Idioma:
En
Revista:
Int Rev Neurobiol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos